CAGR of 7.9% to drive Neurothrombectomy Devices Market to $1,465.2 Billion by 2032

Neurothrombectomy Devices Market Size Worth $1,465.2 Million By 2032 | CAGR: 7.9%

The global neurothrombectomy devices market size is expected to reach USD 1,465.2 million by 2032, according to a new study by Polaris Market Research. The report “Neurothrombectomy Devices Market Share, Size, Trends, Industry Analysis Report, By Product (Clot Retrievers, Aspiration/Suction Devices, Vascular Snares); By End-Use; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market's growth is due to the increasing incidence of acute ischemic strokes fueled by faulty lifestyles, a rise in smokers and drinkers, and a growing elderly population. Neurothrombectomy devices are crucial in retrieving blood clots from cerebral neurovascular blood vessels, improving patient outcomes, and reducing mortality rates. These devices are considered a preferred treatment option for heart strokes.

Acute ischemic stroke is a severe and prevalent form of stroke, particularly among older people, and occurs more frequently in women than men. In the UK, for instance, it is estimated that over 100,000 strokes occur each year, with approximately 1 in 10 individuals experiencing hemorrhage dying prematurely, according to the UK Stroke Association's estimates.

In addition, various government initiatives have been implemented to raise awareness and prevent heart strokes. One notable example is the WISEWOMAN program initiated by the U.S.-based Centers for Disease Control and Prevention (CDC). This program aims to reduce the risk of stroke and promote healthy lifestyles, specifically targeting uninsured women from low-income populations. Such initiatives are vital in increasing awareness about the detrimental effects of strokes within the market, leading to improved prevention and management strategies.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

The market is witnessing significant trends that are driving its growth and evolution. There is a special focus on technological advancements, with the development of advanced devices such as stent retrievers, aspiration devices, and robotic-assisted systems. These innovations are enhancing the efficacy and precision of neurothrombectomy procedures. Additionally, a growing preference for minimally invasive approaches leads to increased demand for devices that enable such procedures. Minimally invasive techniques offer benefits like reduced trauma, shorter hospital stays, and improved patient outcomes.

The emphasis on clinical evidence and research is increasingly placed on gathering robust clinical data to validate these devices' safety, efficacy, and cost-effectiveness. Clinical trials and post-market registries are being conducted to generate real-world evidence and support the adoption of neurothrombectomy devices.

Moreover, collaborations and partnerships between medical device manufacturers and research institutions are facilitating the development of innovative devices and expanding product portfolios. These trends collectively reflect the dynamic nature of the neurothrombectomy devices market and highlight the ongoing efforts to improve stroke treatment outcomes through technological advancements, evidence-based practices, and collaborative initiatives.

Neurothrombectomy Devices Market Report Highlights

  • Clot retriever segment holds the largest revenue share in the market due to its effectiveness in removing blood clots from cerebral arteries and the growing prevalence of ischemic heart diseases alongside product innovations.
  • Hospital segment holds the largest revenue shares of the market and will continue its growth over the forecast period. Due to patient preference for advanced medical infrastructure and skilled surgeons, they ensure comprehensive care.
  • Europe accounted for the significant shares of the market. The region’s growth is based on advanced healthcare infrastructure, high stroke incidence, technological innovations, favorable reimbursement coverage, and key market players
  • The global key market players include Medtronic, Stryker Corporation, Acandis GmbH, Stryker Corporation, Phenox GmbH, Penumbra Inc., and Vesalio.

Polaris Market Research has segmented the neurothrombectomy devices market report based on product, end-use, and region:

Neurothrombectomy Devices, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Clot Retrievers
  • Aspiration/Suction Devices
  • Vascular Snares

Neurothrombectomy Devices, End-Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals
  • Emergency Clinics
  • Ambulatory Surgical Centers

Neurothrombectomy Devices, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Neurothrombectomy Devices Market Report Scope

Report Attributes


Market size value in 2023

USD 741.8 million

Revenue forecast in 2032

USD 1,465.2 million


7.9% from 2023 – 2032

Base year


Historical data

2019 – 2021

Forecast period

2023 – 2032

Quantitative units

Revenue in USD million and CAGR from 2023 to 2032

Segments Covered

By Product, By End-Use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key Companies

Medtronic, Stryker Corporation, Acandis GmbH, Stryker Corporation, Phenox GmbH, Penumbra Inc., and Vesalio.

For Specific Research Requirements

Request for Customized Report

License and Pricing

Purchase Report Sections

  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Request for Discount Pricing